FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Oncologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 3
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 

 


Chair
Vacant

Designated Federal Official
Nicole Vesely, Pharm.D.
Advisors and Consultants Staff (HFD-21)
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland, 20857
(301) 827-7001
Fax: (301) 827-6776
E-mail: Nicole.Vesely@fda.hhs.gov

**Gregory Curt, M.D.
Expertise: Clinical Oncology
Term: 06/10/2008 -10/31/2011
U.S. Medical Science Lead, Emerging Products
AstraZeneca Oncology
P.O. Box 90
Garrett Park, MD 20896

S. Gail Eckhardt, M.D.
Expertise: Medical Oncology
Term: 02/16/2006 - 06/30/2009
Director
Division of Medical Oncology
GI Malignancies Program
University of Colorado Health Sciences Center
12801 E. 17th Avenue
Aurora, Colorado 80010

Jean Grem, M.D., F.A.C.P.CV
Expertise: Hematology/Oncology
Term: 05/05/2008 - 06/30/2011
Professor of Medicine
Department of Internal Medicine
Section of Hematology/Oncology
University of Nebraska Medical Center
987680 Nebraska Medical Center
Omaha, NE 68198

David Harrington, Ph.D.
Expertise: Statistics
Term: 02/16/2006 - 06/30/2009
Department of Biostatistics and Computational Biology
Dana-Farber Cancer Institute
44 Binney Street
Boston, Massachusetts 02115

Michael Link, M.D.
Expertise: Pediatric Oncology
Term: 11/15/2006 - 06/30/2010
The Lydia J. Lee Professor of Pediatrics
Chief, Division of Hematology/Oncology
Stanford University School of Medicine
1000 Welch Road, Suite 300
Palo Alto, California 94304-1812

 

Gary Lyman, M.D. M.P.H., FRCP (Edin)
Expertise: Med.Onc/Hem, Biostats/Epid.
Term: 02/21/2007 - 06/30/2010
Director
Health Services and Outcomes Research Program-Oncology
Duke University Medical Center
Box 3645
Durham, NC 27710

*Virginia Mason, R.N.
Expertise: Oncology Nursing
Term: 07/01/2007 - 06/30/2011
Executive Director
Inflammatory Breast Cancer Research Foundation
P.O. Box 786
Citronelle, AL 36522

Ronald Richardson, M.D.
Term: 02/21/2007 - 06/30/2010
Expertise: Medical Oncology
Consultant
Department of Medical Oncology
Mayo Clinic
200 First Street, S.W., Gonda 10
Rochester, MN 55905

Margaret Tempero, M.D.
Term: 05/05/2008 - 06/30/2011
Expertise: Hematology/Oncology
Deputy Director UCSF Helen Diller Family
Comprehensive Cancer Center
University of California, San Francisco
UCSF Cancer Center
1600 Divisadero Street, Room B726
Box 1770
San Francisco, CA 94115

Wyndham Wilson, M.D.
Term: 05/05/2008 - 06/30/2011
Expertise: Lymphoma/Neurobiology
Chief, Lymphoma Therapeutics Section
Metabolism Branch
Center for Cancer Research
National Cancer Institute
9000 Rockville Pike
Bldg. 10, Room 4N-115
Rockville, MD 20892


PDF requires the free Adobe Acrobat Reader

* Consumer Representative
** Industry Representative, non voting

Back to Top      
  Back to Oncologic Drugs Advisory Committee Info
  Human Drug Advisory Committee Information

Date created: July 22, 2003, Updated: October 14, 2008

horizonal rule